Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - OTHER LONG-TERM ASSETS
Other Long-term Assets URGN - UroGen Pharma Ltd.
2.26 M
LAST VALUE
21.46%
2 YEAR CAGR
48.16%
5 YEAR CAGR
0.00%
10 YEAR CAGR